Indirect immunofluorescence and lymphocyte cytotoxicity experiments demonstrated the presence of a tumor-specific antigen(s) on the surface of cells from an equine sarcoid cell line (Mcl) . Autologous serum (taken from the horse from which the Mcl cells were derived) and sera from three other sarcoid-bearing horses revealed a similar membrane immunofluorescence when reacted with Mcl cells, indicating the existence of cross-reacting antibodies. Results Many tumors, tissue culture cells derived from tumors, and cells transformed in vitro contain tumor-specific antigens which differ from normal tissue antigens of the animal from which the tumor or transformed cells were derived. There are several different types of tumor antigens: (i) virus-specific tumor antigens (4, 7, 12, 18, 20) ; (ii) T antigens (5, 6, 11, 21, 25, 29) ; and (iii) tumor-specific transplantation antigens (TSTA's) (1, 2, 8, 10, 14, 16) . Other, less common types of tumor antigens have been reported to occur in specific types of neoplasia or transformed cells (3, 27) . One Normal equine globulin (NEG) was fractionated from pooled NES using the ammonium sulfate precipitation method of Spendlove (24) . The protein content of the NEG was determined using the method of Lowry and co-workers (17) , and then adjusted to give 15 mg of protein per ml of 0.85% NaCl. Rabbit anti-normal equine globulin (RANEG) was produced in five rabbits by intravenous inoculation of NEG. A 0.1-ml amount of NEG was injected on day 1, followed by 0.25 ml on day 4, 0.5 ml on day 8, and 1.0 ml on days 12, 16, 20, 24, and 28. Then 30 days later rabbits were given 2.0 ml of NEG intramuscularly. Animals were bled 6 days after the intramuscular injection, and the serum was harvested and stored at -20 C.
The method of Spendlove (24) was used to conjugate RANEG with fluorescein isothiocyanate (FITC). The conjugated antiserum (RANEG-FITC) was then used to stain cells in suspension according to a modification of the method of Pearson and co-workers (19) . Tissue culture cells were trypsinized off the surface of culture vessels using phosphate-buffered saline (PBS} containing 0.5% trypsin plus 0.025% ethylenediaminetetraacetic acid. After washing the cells three times with PBS, cell viability was determined by the trypan blue exclusion test. Approximately 5.0 x 106 viable cells were suspended in 0.05 ml of the appropriate test or control sera. This suspension was incubated for 45 min in a 37 C water bath. After washing the cells three more times in PBS, the cells were incubated in the dark for 45 min at 37 C 714 on September 23, 2017 by guest http://iai.asm.org/ Downloaded from with 0.05 ml of 1:5 RANEG-FITC. Unreacted, conjugated antiserum was removed by washing the cells three times with PBS. The stained, packed cells were suspended in 1 or 2 drops of buffered glycerol. The cell suspension was placed on a clean microscope slide, after which a cover slip was applied and sealed with fingernail polish.
A blocking test was conducted prior to the indirect fluorescent antibody (FA) technique by adsorbing the unlabeled primary sera (i.e., Mcl, Val, Tuc, and Ttl sera) with Mcl cells to remove specific antibodies to tumor antigens. One milliliter of each of the primary sera was incubated with 107 Mci cells overnight at 4 C. The cells were removed by centrifugation and adsorption was repeated for 1 h at 37 C by using fresh Mcl cells. The suspension was centrifuged, and the adsorbed sera were pipetted off and used in place of unadsorbed primary sera in the indirect FA technique.
A Zeiss Universal microscope with a 12-V 100-W tungsten-halogen quartz illuminator and a darkfield ultra-condenser for blue light fluorescence was used. Photomicrographs were taken with a Zeiss 35-mm camera and Kodak Tri-X-Pan film (ASA 400).
Colony inhibition techniques. The same sera which were used in the indirect FA test were also used in the colony inhibition (CI) technique (26) . These sera were incubated with Mcl cells in culture in an attempt to detect tumor-specific antigens on Mcl cells. The inhibition of colony formation by the test sera was based on a comparison with normal equine or fetal bovine sera. Experiments were also conducted in which the guinea pig complement was either omitted or heat-inactivated before use.
Lymphocyte cytotoxicity techniques. A modification of the techniques of Sinkovics and co-workers (22, 23) and Kurth and Bauer (15) were used in an attempt to detect lymphocytes which were cytotoxic to Mcl cells. Lymphocytes were separated from the blood of normal horses and from the horse from which the Mcl cells were derived (Mcl horse) by using the technique of Joel (13 (Fig. 1) .
The cell membrane was the only portion of the cell which fluoresced. The membrane never exhibited a complete ring of fluorescence, but instead had discrete patchy areas of fluorescence scattered over the entire membrane. By focusing up and down on the suspended cells, areas of speckled fluorescence were detected at all levels of the cell membrane. When NES was used in place of Mcl sera, there were a few cells which retained the stain; however, less than 10% exhibited the membrane immunofluorescence. Antibodies to tumor-specific antigens were probably present in the sera of sarcoid-bearing horses, and these antibodies probably reacted with surface antigens of Mcl cells in the colony inhibition test; however, due to their noncytotoxicity they were not detected.
Lymphocyte cytotoxicity experiments have been used in the past to demonstrate a cellmediated immune response to autologous tumor cells (22, 23 
